Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments

BACKGROUND: High-risk neuroblastoma has an overall five-year survival of less than 40%, indicating a need for new treatment strategies such as angiogenesis inhibition. Recent studies have shown that chemotherapeutic drugs can inhibit angiogenesis if administered in a continuous schedule. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Dieter, Christofferson, Rolf, Stridsberg, Mats, Lindhagen, Elin, Azarbayjani, Faranak
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667491/
https://www.ncbi.nlm.nih.gov/pubmed/19284605
http://dx.doi.org/10.1186/1479-5876-7-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667491/
https://www.ncbi.nlm.nih.gov/pubmed/19284605
http://dx.doi.org/10.1186/1479-5876-7-16

Ejemplares similares